Survey Study for Pain Management, Wound Care, Scar Care or UDT
NCT ID: NCT02195063
Last Updated: 2015-01-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
10000 participants
OBSERVATIONAL
2013-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The initial survey for pain management, wound care, scar care or UDT will be given to the patient by their providers during their office visit.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Herniorrhaphy
NCT06215859
Fentanyl Administered Intraorally for Rapid Treatment of Orthopedic Pain
NCT00685295
Open Label, Safety Study of EN3270 in Patients With Moderate to Severe Non-malignant, Chronic Pain
NCT00485225
Evaluation of Drug Utilization Patterns for Extended Release/Long Acting Opioids and Comparator Products
NCT02925806
Pharmacokinetic Characterization of the Active, Separated System With PK Controller (Fentanyl Iontophoretic Transdermal System, 40 Mcg Fentanyl Per Activation).
NCT01750060
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The initial survey for pain management, wound care, scar care or UDT will be given to the patient by their providers during their office visit.
Follow-up surveys will be given at 30, 60, and 90 days. These surveys will be collected by e-mail or follow-up calls from Datum Research, LLC, contract research organization.
Data collection for this study will be derived through the 4 patient surveys (initial, 30 day, 60 day, and 90 day) and the prescription written by the provider.
The survey study will enroll patients until December 31, 2014, or until sufficient numbers have been achieved.
Rahm Foundation will continue the study until:
* Sufficient information has accumulated to meet the scientific objectives of the Study (i.e. numeric targets or effect size)
* The feasibility of collecting sufficient information diminishes to unacceptable levels, poor enrollment, loss to follow-up and/or
* Other methods of gathering appropriate information become achievable or are deemed preferable.
Datum Research will need to have access to the prescription to see what compound was prescribed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pain management
patients undergoing transdermal treatment for pain
No interventions assigned to this group
Scar care
patients undergoing transdermal treatment for scars
No interventions assigned to this group
Wound care
patients undergoing transdermal treatment for wounds
No interventions assigned to this group
UDT
patients receiving urinary drug tests
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Minors
* Prisoners
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Datum Research, LLC
UNKNOWN
Rahm Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Blueprint Pathways
Nashville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
Blueprint Pathways
The Rahm Foundation
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RAHM 1001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.